Skip to main content
PLOS One logoLink to PLOS One
. 2024 Apr 2;19(4):e0298972. doi: 10.1371/journal.pone.0298972

Understanding antibiotic use in the community setting in Thailand: Does communication matter?

Malee Sunpuwan 1,*, Sureeporn Punpuing 1, Wipaporn Jaruruengpaisan 1,*, Heiman Wertheim 2
Editor: Anselme Shyaka3
PMCID: PMC10986969  PMID: 38564533

Abstract

Background

It is known that the misuse and overuse of antimicrobials leads to antimicrobial resistance (AMR). Effective communication between dispensers and users is thus crucial in reducing inappropriate antibiotic use.

Objective

This study aims to gain a better understanding of communication around the use of antibiotics in the community and seeks potential implementation strategies to change dispenser and user practices in communication aspects.

Methods

Qualitative methods were employed, including in-depth interviews with 18 drug suppliers and 16 community members, and eight focus group discussions with key informants. Data were collected in the Kanchanaburi Demographic Health Surveillance System in urban and semi-urban communities in the western region of Thailand. The thematic analysis included communication quality, communication and imbalanced power, and misconceptions and instruction. The OpenCode qualitative software program was employed.

Results

The study revealed that the quality of communication was significantly influenced by the interaction of antibiotic dispensing with language and information. This interaction creates communication constraints between those dispensing antibiotics and the recipients, resulting in a less-than-optimal exchange of information. Consequently, users received limited information concerning the proper use of antibiotics. Furthermore, power imbalances and communication dynamics were perpetuated, mainly stemming from varying levels of access to and knowledge about antibiotics. This imbalance in power dynamics became evident between those dispensing antibiotics and the users. Users, as well as dispensers lacking proper qualifications, found themselves in a precarious position due to their inadequate knowledge of antibiotics. Moreover, it is noteworthy that misconceptions often conflicted with antibiotic instructions, leading to challenges in adhering to antibiotic regimens. These challenges primarily arose from misconceptions about antibiotics and concerns about potential side effects, particularly when users started to feel better.

Conclusions

The findings highlight the importance of enhancing communication between dispensers and users through future interventions. These interventions should aim to bolster user understanding of antibiotics and provide clear, trustworthy instructions for their proper usage. Investigating innovative communication methods, such as the use of QR codes, presents a promising avenue for consideration. By addressing these communication gaps, we can advocate for the appropriate utilization of antibiotics and mitigate the prevalence of AMR.

Introduction

The threat of antimicrobial resistance (AMR) to public health is of utmost concern, considering the diminishing effectiveness of antibiotics worldwide [1]. Thailand, like many other countries, is not exempt from this threat [2, 3]. In response, the Thai government has initiated various policies and programs aimed at improving antibiotic prescribing practices, increasing public awareness of appropriate antibiotic use and understanding AMR [35]. Notably, the “Antibiotics Smart Use (ASU) program” was launched in 2017, with the goal of reshaping antibiotic prescription practices and promoting responsible antibiotic use. Community education campaigns utilizing diverse educational resources such as infographic posters and pamphlets have been deployed to educate healthcare professionals and the general public [4, 5]. These concerted efforts have demonstrated promising results in curbing unnecessary antibiotic use [6] and elevating awareness levels [7]. Furthermore, national surveys tracking public knowledge and awareness of AMR and proper antibiotic use have indicated incremental improvements [8]. Nevertheless, antibiotic misuse is still challenging.

The challenge of antibiotic misuse, resulting from a complex interplay actors involving policymakers, healthcare professionals and the general public, underscores the gravity of this issue [9]. These factors are intricately linked to variations in governance, drug regulations, pharmaceutical market structures and cultural influences, all of which contribute to the misuse of antibiotics [10, 11]. Furthermore, a lack of knowledge among healthcare professionals, defensive medical practices, suboptimal patient communication and time constraints during consultations significantly contribute to the inappropriate dispensing of antibiotics [1215]. User behavior, marked by both misuse and overuse, is heavily influenced by social norms and deeply ingrained beliefs [1620].

Effective communication is widely recognized as pivotal in healthcare to ensure accurate understanding and successful treatment [21]. The global focus on antibiotic dispensing, which hinges on communication between dispensers and users, has intensified due to its connection with the development of AMR [2224]. This connection is rooted in the inadequate emphasis on completing the full antibiotic course [25, 26], often caused by insufficient consultation time and ineffective communication skills [2729], as well as an imbalance in the power dynamic between healthcare providers and clients, leading to premature cessation of antibiotic use [27, 30].

User beliefs about antibiotics often conflict with the instructions provided, significantly influencing adherence to treatment plans. These beliefs often stem from misunderstandings, fear of side effects and a sense of improvement in health [31]. Misunderstandings manifest when users overestimate their knowledge or lack thereof, leading to antibiotic misuse, such as the belief that antibiotics can effectively treat non-bacterial ailments such as coughs, colds, body pain and flu [3236]. Fear of side effects and premature discontinuation of antibiotics due to a sense of improvement, despite instructions to the contrary, also influence user behavior [37, 38]. Thus, in this study, beliefs are characterized as misconception, indicating an inaccurate or flawed understanding [39] of how antibiotics function, what side effects are or the reasons behind occurrences.

A systematic review of communication interventions aimed at improving antibiotic use among the public highlighted a dearth of research conducted in Thailand [40]. Among the existing studies, a critical discovery was that improved communication regarding antibiotic knowledge between public health officers and grocery shop owners could reduce the inappropriate sale and use of antibiotics in the community [41]. Another study in Northern Thailand underscored the role of educational activities and local language in enhancing antibiotic attitudes and practices [42].

While studies on communication between health professionals and patients about medications have been a focus for decades [43, 44], limited research in Thailand has encompassed both formal and informal dispensers, as well as users, within the same study. Therefore, this study seeks to comprehensively examine the broader spectrum of dispensers and users, which includes both formal and informal dispensers. It aims to shed light on the comprehensive examination of antibiotic practices and communication within community settings in developing countries such as Thailand.

Methods

Study site

This paper reports on results from the study conducted at the Kanchanaburi Health and Demographic Surveillance System (HDSS) in Thailand, which is one of the INDEPTH (International Network for the Demographic Evaluation of Populations and Their Health in Developing Countries) community-based study sites. It is a sub-study of the project on “Community-level antibiotic access and use in low- and middle-income countries: Finding targets for social interventions to improve rational antimicrobial use”, known as the ABACUS (AntiBiotic ACcess and USe) study. Its focus is on appropriate access and use of antibiotics between six different health and demographic surveillance sites in low- and middle-income countries in Asia (Bangladesh, Vietnam and Thailand) and Africa (Mozambique, Ghana and South Africa) [45]. For further details, see https://abacus-project.org/project/. The overall aim of the project is to assess and compare community-based antibiotic access and consumption, as well as the underlying factors, in six countries across Africa and Asia. Additionally, the project aims to systematically investigate understandings of antibiotic use, along with related health-seeking behaviors and the broader contextual factors influencing these behaviors. As this sub-study is conducted in Thailand, which is an upper- middle-income country in Asia, it contributes to a better understanding of antibiotic usage.

The Kanchanaburi HDSS is located in western Thailand and was established in the year 2000, with a cohort size of approximately 43,000 in 2004. This study, however, included about 8,000 persons residing in urban and semi-urban areas of the Kanchanaburi HDSS [46]. Two phases of data collection took place in urban and semi-urban communities of the Kanchanaburi HDSS: 21 July 2016–19 June 2017 for the first phase and 26 August–15 September 2018 for the second phase.

Data collection techniques

This paper presents the study’s qualitative findings, which involved two phases of data collection. During the first phase, 34 in-depth interviews (IDIs) were conducted, involving 18 drug suppliers and 16 community members who use antibiotics. Additionally, six focus group discussions (FGDs) were held with community members. In the second phase, we conducted follow-up IDIs with eight drug suppliers and two more FGDs with community members, addressing important issues identified in the initial phase. The interview and discussion guides are available in the S1 File. Data collection for the IDIs and FGDs was carried out by three researchers (M.S., S.P. and W.J.) who have extensive training and experience in qualitative research and have been actively involved in the Kanchanaburi HDSS since 2000. The core questions used in this study were standardized across all the other INDEPTH ABACUS study sites.

Sample selection

In-depth interviews (IDIs)

The key informants for IDI were heads or main responsible persons for drug dispensing and community members located in the Kanchanaburi HDSS. In this study, the key informants for antibiotic dispensers (suppliers) were those who worked at both public and private health facilities. Thailand’s healthcare system comprises three levels: primary (sub-district health promoting hospitals), secondary (district, provincial and regional hospitals) and tertiary (university and large private hospitals). Public and private sectors play vital roles, with public facilities serving about three-quarters of the population. Informal healthcare providers such as pharmacies and traditional healers also contribute to the healthcare landscape [4749] (see the S2 File for further details).

Drug suppliers

At the tertiary level, there was one public provincial hospital located in our study area that was willing to participate in this study for the two phases of data collection. Two health facilities were recruited to our study for the secondary level of healthcare service for the first and second phases. There were three private hospitals located in our study area, two of which agreed to participate in the first phase and one in the second phase.

The primary level includes healthcare services in the public and private sectors. The public sector included community health promotion hospitals (CHPs) and local health centers, whereas the private sector included private clinics and drugstores. There were 12 CHPs and local health centers in our study area. According to our qualitative research methodology, designed in addition to budget and time constraints, three key informants from the CHPs were interviewed in depth in the first phase. The criterion to select CHPs was based on the coverage population under each CHP, with the first, second and third ranking being selected. Two CHPs participated in the second data collection phase.

The researchers approached private clinics through local knowledge and our networks by providing relevant research information to the owner. The Kanchanaburi provincial health office reported that there were 101 private clinics operated by different levels of health profession in our study area. The selection criterion for private clinics was based on the willingness of the private clinic owner. The research team was able to recruit two private clinics in the first phase. However, because the second phase involved following up on the issues identified in the first phase with the same drug suppliers, both private clinics declined to participate in this second phase.

The health provincial office provided a full list of licensed pharmacy shops in our study, which comprised 96 shops. A health provincial officer–a pharmacist–contacted drugstore owners because of participants’ trust in local authorities. Finally, six drugstore owners agreed to participate in the first data collection phase. One drugstore was selected for IDI for the second phase because it had the highest number of antibiotic encounters. The owners or pharmacists were the IDI key informants.

Although only medical doctors or licensed pharmacists can dispense antibiotics, some local grocery stores sell drugs and antibiotics by laypersons. Based on community leaders’ and village health volunteers’ networks, two grocery shops were willing to be interviewed in depth in the first phase but not in the second.

In this study, the researchers did not substitute the declined health facilities (private hospital, CHP, private clinic and drugstore) because we wanted to follow up with the interesting issues that came up during the first phase.

Community members

Another group of key informants for IDI was the community members, who are antibiotic users. Sample selection was based on a simple random sampling technique. Selection of community members was made randomly from the HDSS database, which aimed to use standardized methods for studying antibiotic use in six low- and middle-income countries. This reflected the full geographical range of the site. A sampling frame was employed from two sources of data; the first source was a list of household members in the Kanchanaburi HDSS database and the second source was a list of clients that received antibiotics from a health-promoting hospital during the year before the IDI. The population in the sampling frame was stratified into five groups: age 18–59 years (male and female), age 60 years or older (male and female) and mothers of children aged 5 years or younger. The researchers employed the SPSS simple random command to select key informants randomly. The 16 community key informants consisted of two males and two females aged 18–59 years, two males and two females aged 60 years or older and eight mothers or guardians of children under 5 years old. The IDI data collection from community members was done only in the first phase.

The information gathered included experience of obtaining and using medicines by community members, focusing on where medicines are obtained, how they are used and for what reasons. In addition, the researchers collected information related to issues of accessing treatment, supplier/sellers of medicines and the medicines per se.

Focus groups discussions (FGDs)

Eight FGDs were conducted and divided into two phases, six in the first phase and two in the second. Each FGD consisted of six to eight participants. Participants were recruited through the community network, which involved collaboration between the research team and community members in the study areas. The selection of participants was based on the population of the Kanchanaburi HDSS from which the individuals were chosen.

In the first phase, the first four FGDs included two groups of males and two groups of females, with participants aged 18–29 years (two FGDs) and 30 years or older (two FGDs). The other two FGDs included village health volunteers and the elderly.

In the second phase of the study, we focused on common themes that emerged from the first phase. It was determined that two specific groups of participants played a crucial role in shaping these themes: males aged 60 years or older and females aged 18–59 years.

The standardized discussion guideline for the FGD had been used in all sites of the INDEPTH ABACUS study (see the S1 File). These core questions aimed to gather information on accessing treatment, medicines, suppliers/sellers and antibiotic resistance.

Study procedures

Convenient places and times for the participants were the most important issues for the researchers to conduct IDI and FGD. IDIs were conducted at participants’ houses, clinics and workplaces, whereas FGDs were conducted at community centers such as community halls, meeting rooms, pavilions and temples located in the study areas. M.S., S.P. and W.J. conducted all the IDIs, whereas M.S. moderated all the FGDs with assistance from S.P. and W.J. They used the Thai dialect to run the IDI and FGD, with discussion guidelines encouraging dialogue with optional probes. The IDI lasted 45–60 minutes, whereas the FGD took 60–90 minutes. An audio record was used for each IDI and FGD if participants consented. One participant in our study did not permit audio recording of the IDI but alternatively gave consent for note-taking.

Data analysis

The audio transcription was conducted in Thai to facilitate data analysis, with the analysis itself also carried out in Thai. Line-by-line coding was performed using the OpenCode program [50]. Subsequently, thematic analysis and codes were assigned to the material. M.S. and S.P. determined the thematic saturation. This study applied the 32-item Consolidated Criteria for Reporting Qualitative Studies (COREQ) checklist [51].

Sample characteristics

There were a total of 88 individuals who participated in the FGD and IDI, including community members and suppliers. Community members included 30 males and 40 females. Most had completed primary school and were aged between 18 and 82 years. A majority of them, almost two-thirds or 60%, were involved in sales and service, working for wages and living in non-poor households. All have access to health services under universal healthcare. Eighteen suppliers participated in this study, including ten females and eight males. Most had completed a bachelor’s degree in pharmacy and their ages ranged from 29 to 72 years.

Results

The results are presented according to the main themes that emerged during the data collection: communication quality; communication and imbalanced power; and misconceptions and instruction. Communication quality emphasizes the dispensing behavior and communication between antibiotic dispensers and users. Communication and imbalanced power focuses on the space linked with the power to control antibiotics. In this study, power is defined as the ability to influence actions, encompassing both ‘power over’ and ‘power to’. ‘Power over’ denotes control over decision-making, resources, ideas and meanings, whereas ‘power to’ relates to an individual’s ability to take action [52]. Thus, power is observed through the interaction between dispensers and users in health facility and home settings, involving access to and knowledge of antibiotics as well as the utilization of antibiotics. Finally, the theme of misconceptions and instruction reveals the misconceptions that contradict antibiotic instructions, affecting antibiotic adherence.

Theme 1: Communication quality

This theme focuses on communication between dispensers (suppliers) and users (community members) and is mainly related to communication quality. Both dispensers and users have raised concerns of communication constraints, language use and incomplete information.

Constraints to communication (i.e., comprehension) at different healthcare system levels seem to have similarities and differences. The major constraints to effective communication appeared at the tertiary, secondary and (less so) primary care levels in the public sector. By contrast, the least constraints appeared at the private health facilities. One explanation may be that the more highly managed and bureaucratic procedures in the public healthcare setting are more complex and confusing for the client than the more service-oriented system in the private setting.

In the public tertiary care setting, the interaction between dispensers and users is constrained by time limitations. This is primarily caused by overcrowding, especially when doctors initiate physical exams simultaneously and prescriptions are concurrently sent to the pharmacy section. As a result, the pharmacy section becomes overwhelmed by a high volume of medical orders, leading to a scarcity of time for providing instructions.

"… in the late morning, when the patients accumulate, there are long queues, and we have to talk fast. Some patients can understand the information, but others may not."

(IDI, supplier, female, age 40+, public hospital)

The communication constraints observed at the tertiary care level are also prevalent at the public secondary care level. Additionally, one participant noted that communication challenges are not solely attributed to the healthcare system but are influenced by factors such as the patient’s time and surrounding environment.

"There are many factors (affecting the difficulty in communication) such as when the patients were in a hurry or there are too many patients … moreover, it is noisy from the megaphone (calling the “client’s name")."

(IDI, supplier, female, age 40+, public hospital)

At the public primary care level, the atmosphere is generally more laid back, allowing staff to dedicate ample time to interacting with patients. Nonetheless, a challenge arises when communicating with specific groups, such as cross-border migrants who are not of Thai origin. This difficulty arises from their limited understanding of the Thai dialect.

"Now we have problems in communicating with migrants from Myanmar. Some can speak Thai a little bit, but some cannot speak at all. Often, there is a supervisor from the workplace of the migrants to serve as translator and advocate. However, we are not sure whether the clients will follow our instructions on proper use of the drugs."

(IDI, supplier, female, age 40+, public hospital)

In contrast, the private healthcare setting offered greater flexibility in terms of time for patient communication, providing ample opportunity for interaction between healthcare providers and the individuals seeking care. The dispenser employs various strategies at this facility to ensure patient attentiveness toward the provided instructions.

"We normally give direct information to the patients. Apart from that, we observe how they respond to our explanation to assess comprehension. When we complete the instructions, we will ask whether they understand how to take the drugs. We also use some techniques to focus their attention, such as asking what types of medicines they are allergic to, or addressing them by their name."

(IDI, supplier, male, age 50+, private hospital)

The community members discussed that they were given information about antibiotics related to their illness but did not fully understand the explanation. Some felt that the information was insufficient and wanted to know more about antibiotics.

"When talking about germ killer medicine, we only take it because they told us to, without any explanation. They only tell us that this is a germ killer medicine, but do not explain what types of germs it kills."

(FGD, community members, male, age 60+, urban)

Apart from time constraints that limit the information received, language use is another issue raised by both the suppliers and community members. The technical terms used by dispensers are often unfamiliar to users: for instance, “antibiotic resistance”. This term sometimes leads to confusion among community members. Some of the community members mentioned that sometimes they were given an explanation as to why they had to finish all the antibiotics but they could not understand the term “antibiotic resistance”.

"I do not know. I heard them say “drug resistance”. I do not know what they are referring to.

(IDI, community members, female, age 47, semi-urban)

The community members also needed simple words to understand the content rather than the technical term that they rarely understood. The community members from the FGD mentioned that the technical term confused them, making it hard for them to follow the content.

"The providers have to use simple words that the villagers are familiar with; then they will understand. For example, I used to invite a nurse to speak during a meeting, and she communicated using simple words, avoiding technical terms to ensure the villagers could comprehend. This made it easier for them to understand the content.”

(FDG, community members, female, age 15–59, semi-urban)

Although time constraints were different between the levels of the healthcare service system, the interpretation of information on antibiotics seemed to be similar. This reflects that the dispensers are familiar with such information. Imbalance of information about antibiotics between dispensers and users occurred, resulting in most users receiving or retaining imperfect information about the use of antibiotics.

"We need to ask the pharmacist how to take the tablets. If there is more than one pill, do I take them together or at different times? I get confused."

(FGD, community members, female, age 15–59, semi-urban)

While the importance of providing instructions for antibiotic use was acknowledged, our participants noted that when antibiotics are obtained from grocery stores, there are no accompanying instructions. In this scenario, users simply inform the seller of the specific antibiotic they wish to purchase.

"They (sellers at grocery shops) do not tell anything about the medicine we bought."

(FGD, community members, female, age 18–30, semi-urban)

Theme 2: Communication and imbalanced power

This theme focuses on the relationship between dispensers and users regarding the access and utilization of antibiotics. The problem of accessing antibiotics is closely tied to the choice between public and private healthcare facilities, while the location of administration influences the issue of their usage, whether it occurs in the health facility or home setting. These concerns have been brought up for consideration.

Although they have a health scheme that provides them with affordable or free healthcare services, numerous Thai still pay out of pocket when the prescribed medication was not what they expected. As a result, they opt for private sector services, thereby incurring the entire expense. Some suppliers acknowledge that community members are entitled to free access to medication, yet some individuals even opt for informal alternatives when they are unable to obtain the desired medication.

"We have concerns about the clients’ health scheme, some of them can get service with no cost. Anyway some choose to buy medicines from drugstores. If they do not feel better, they come to see us. If they ask us for a specific medicine which we refuse to dispense, they say that they will just go buy it from the drugstore."

(IDI, supplier, female, age 40+, public hospital)

Community members have additionally conveyed that in instances where they are unable to obtain antibiotics from public health facilities, they resort to purchasing them from local drugstores.

"Once I went to see the doctor at the hospital and I did not get antibiotics, I decided to buy Amoxicillin from the drug store because I know that I had tonsillitis."

(FGD, community members, elderly, age 60+, semi-urban)

Access to antibiotics reflects how power is exercised. At public healthcare facilities, the users have less power to negotiate with dispensers. In other words, they let the healthcare providers be a legitimate interpreter in order to dispense antibiotics to them.

"The doctor told me that this medicine is a “germ killer”. I can understand easily that taking the germ killer will relieve my sickness quickly … I never doubted the doctor; I just followed his instruction on how to take the medicine after or before meals. I did not have knowledge on this, so I did whatever they told me to do. However, if I take the medicine and I am not cured, I will buy new medicines from another source."

(IDI, community members, male, age 45, semi-urban)

By contrast, the clients have some power to bargain when they are at private health outlets. Private health facilities are more patient-oriented, which allows the users to exercise power. For instance, they can ask for medicine if they feel they have another choice.

"Some clients, they are not happy with amoxicillin, they asked for Augmentin. We need some times to explain to them why the doctor starts with amoxicillin. Some clients are still not satisfied with our explanation, in this case, we have to consult the doctor."

(IDI, supplier, male, age 50+, private hospital, urban)

Overall, however, it seems that users have the most power at the unlicensed shops that sell antibiotics. Here, they generally get what they demand. Our participants mentioned that sometimes community members just named the medicine they wanted, and these included antibiotics.

"At the drug store, they will buy these medicines [T-C mycin, penicillin (500,000), ampicillin] for wound and sore throat."

(FGD, community members, female, age 18–59, semi-urban)

Although the users have less power in the health facility setting, some users gain control of antibiotic use when they take matters into their own hands. After getting antibiotics, some community members reported that the use of antibiotics depends on their own decision once the antibiotics are with them.

"We got instructions, but sometimes we did not follow them. It depends on ourselves because we are already feeling better."

(IDI, community members, male, age 60+, semi-urban area)

Theme 3: Misconceptions and instruction

The main focus is on the contradiction between people’s misconceptions and the recommended antibiotic guidelines, leading to a lack of adherence. Although antibiotic practices are influenced by several factors, individuals’ misconceptions are one such factor that affects whether they choose to follow the instructions provided or not, which directly affects antibiotic adherence.

Dispensers at formal healthcare facilities, whether public or private, always provide both oral and written instructions to patients or users and mostly advise them to complete the course of antibiotics.

"For antibiotics, some customers specify their names. I advise them to finish the entire pack; they must take the full course. Some people ask how many days they have to take it. I dispense one pack at a time and advise them to finish it all. If the symptoms are still not completely resolved, then I ask them to come back and receive more medication. Typically, I dispense at least 3 days’ worth of amoxicillin and 5 days’ worth of antibiotics for patients with urinary tract infections.

On the medication bag, I provide the written instruction (i.e., medication for infection and advise taking all of them)."

(IDI, supplier, female, age 42, pharmacy shop, semi-urban)

Community members have verified that the information provided is consistent in both oral and written forms.

"Actually, the pharmacist told me how to take the medicine and also mentioned in the written instruction how many times a day and before or after meal."

(FGD, community members, elderly, age 60+, semi-urban)

However, users stopped taking antibiotics once they experienced relief. In the FGD with village health volunteers, it was a surprise that even among these trained volunteers, who know that they have to complete the full dose of antibiotics in whatever conditions, only two in seven participants said that they took the complete dose of the antibiotics when they were ill. The others indicated that they stop the antibiotics when they feel better. This shows how ingrained this practice is in the community.

Participant 1: I stop, when I feel better

Participant 2: I took it for only 2 days

Participant 3: When I feel a little bit better, I stop

Participant 4: Somebody said the antibiotic is dangerous, I didn’t dare to take a lot of it

(FGD, community members, female, village health volunteers, urban)

In addition to the village health volunteers’ views, community members also confirmed their tendency to prematurely discontinue antibiotic usage when they feel improvement. Information gathered from seven FGDs and nine IDIs with community members confirmed that many stopped taking the antibiotics as instructed.

"I think only 20 percent of those community members finish all antibiotics as indicated in the instruction."

(FGD, community members, female, age 18–59, semi-urban)

After getting the antibiotic instructions, whether community members follow the instructions or not is sometimes linked to their level of knowledge. One of the dispensers indicated that knowledge about antibiotics would help in adherence.

"They have the knowledge, but each individual has a different level of knowledge. Those who care about their health will seek accurate information and take the antibiotic properly."

(IDI, supplier, female, age 42, urban)

Although most community members believe in the curative powers of antibiotics for their illnesses, many people try to avoid taking them. This is due to the fact that they fear the side effects and interaction with other medications they take. Thus, they try to take less or stop taking antibiotics as soon as possible and limit overall antibiotic usage.

"Q: From the instruction to finish all of them (antibiotics), some of you told me you stopped when you felt better. Do any of you do the same?

Participant 6: Yes, when I got rid of sick, I stopped. I am afraid that it may affect the drug I take daily. "

(FGD, community members, female, age 30+, urban)

The dispenser also corroborated these fears, stating that some community members are apprehensive about the antibiotics’ side effects and specifically request fewer such medicines. For instance, one individual expressed concern that antibiotics might harm their kidneys and liver, leading them to request only two antibiotic pills from the pharmacy.

"He(customer) told me that he was afraid of it (antibiotics) because it is going to destroy his kidneys and liver. He was really afraid and asked me for only two antibiotic pills."

(IDI, supplier, female, age 33, pharmacy shop, urban)

Discussion

This study attempts to understand the dispensers’ and users’ communication, allowing the researcher to find interaction between the two key factors. Understanding antibiotic dispensing and usage with regard to communication is important for designing and implementing appropriate interventions to address the issue in the broader public health interest.

Our findings point out that constraints in communication occur due to overcrowding and rushed processing of a large number of patients, limiting the time for client education. This situation is particularly prevalent in public tertiary and secondary care settings. Additionally, a lack of communication skills is a significant deficit among some dispensers. These factors may lead to imperfect information exchange and confusion about the indications for antibiotic use. Previous studies found that a shortage of consulting time and poor communication skills led to inadequate explanations for patients and inappropriate antibiotic use [2729]. The language used in communicating with clients is another concern of our study because it was found that users were less likely to understand the dispenser’s language in certain situations. This can lead to misunderstanding about antibiotic use. A previous study suggested that plain and simple language is necessary for effective communication about antibiotics [53]. Furthermore, we should consider specific groups, such as migrants with limited proficiency in the Thai dialect. To address this issue, we propose the use of QR codes containing online information presented in pictograms or the languages spoken by migrants. This approach can effectively convey medication information and enhance comprehension [54], as a previous study found that 87% of migrant workers in Thailand owned smartphones [55].

One of the important findings in our study is that the term “antibiotic resistance” is almost universally misunderstood or unknown among people at the village level. This finding confirms the results of a previous study in Thailand, which found that community residents were not familiar with the term “antibiotic resistance”. This may be due to the fact that they never heard, never believed and/or never feared drug resistance [56]. Thus, our findings suggest that it is important to address this issue by providing training or conducting workshops for dispensers to enhance communication skills, particularly communication using lay language. Additionally, integrating QR codes with easily understandable pictogram-based online information, a strategy proven effective in previous research [54], may help to increase antibiotic compliance and overall satisfaction of the users. This approach is appropriate, as the national survey revealed that 84.5% of Thais aged 6 years and over own a smartphone and approximately 82.3% of the population in the study area own a smartphone [57].

Another concern of our study is the practice of buying antibiotics for self-medication for mild illness from grocery stores without instructions. Medications from these shops are mostly dispensed by non-qualified dispensers. This indicates that community members in the study areas can easily obtain antibiotics from individuals who are not qualified dispensers. A previous study found that non-qualified dispensers significantly aggravate the inappropriate use of antibiotics in the community setting [58]. A previous study also found that patients who received antibiotics without a prescription were more likely to stop when their symptoms improved compared to those with a prescription [59]. However, Thailand has a national drug law that allows antibiotics to be dispensed by doctors, pharmacists and health authorities. Ironically, the fact that antibiotics can be bought over the counter without a prescription means that non-qualified sellers can appear qualified to the uninformed user. Thus, antibiotics are distributed through several channels [60], including legal and illegal distributors [61]. Therefore, a national strategy aiming to improve antibiotic dispensing and reduce non-essential and incomplete use of the drugs also needs to focus on private health facilities, particularly those with unqualified dispensers. This could be one of the effective measures for controlling bacterial resistance. In addition, this finding reinforces that effective instructions, law enforcement and prescription are critical for managing antibiotics in the community setting.

A previous study pointed out that promoting responsible use of antibiotics necessitates acknowledging the significance of power dynamics and autonomy within the healthcare system [26]. Thus, imbalanced power in communication is another concern of our study. The study addresses the issue of imbalanced power in communication, defining power as the ability to influence actions, encompassing both “power over” and “power to”. The research observes power dynamics between dispensers and users in both health facility and home settings. This involves access to and knowledge of antibiotics, as well as their utilization. The literature reveals that access to power and resources is negotiated in everyday life [62]. Thus, the health facility setting is not only a clinical space but also a social space in which unequal power relations occur [63]. There is a power imbalance between healthcare providers and clients, particularly in healthcare settings where patients are most likely to be subordinated [27, 30]. Our study found different levels of imbalance of power between antibiotic dispensers and users. At the tertiary and secondary care levels, such an imbalance seems stronger than at the primary and private healthcare levels, where the power of health service providers over users was maintained. This finding reinforces the results of a qualitative study in Australia, where healthcare providers wield power over customers [64]. Similarly, a qualitative study in Spain indicated that service providers have power over users in antibiotic prescribing [65]. The imbalance of power is less in the private sector due to the fact that they are more customer-oriented and less bureaucratic. Notably, the power advantage shifts to the user interacting with the unlicensed dispensers and it can be said that the customer has power over unlicensed dispensers. This aligns with observations in Ghana, where sellers sell antibiotics even when they do not agree with the customers’ conditions [66]. In highly regulated and managed healthcare settings such as tertiary and secondary care outlets, users may feel a socio-cultural pressure to behave as “good patients” in the eyes of dispensers, which allows dispensers to have power over users. In that space, the user’s role is passive and compliant, and the client is uncomfortable to speak up [27, 67, 68]. Conversely, when the balance of power is more level, the user will feel more confident in speaking up. Not only access to but also knowledge of antibiotics creates a power imbalance. Our study found that users do not necessarily understand the exact nature of their condition and may not understand their treatment options. Thus, they defer their decisions to the dispensers as the legitimated interpreters for their illness.

In contrast, in the home setting of control over antibiotic use, community members have full power to regulate its usage. Exercising this power to use with only limited knowledge of antibiotics may lead to the inappropriate use of these powerful medicines. In addition, lacking knowledge of antibiotics may be a symptom of a more significant health illiteracy problem in parts of society. Health literacy recognizes the ability to understand and critically evaluate health information and make health-related decisions [69]. Previous studies in other parts of the world have also pointed out that education and health literacy play a crucial role in the reduction of inappropriate use of antibiotics [20, 7074]. Thus, our findings call for enhancing health literacy, which may influence the dispenser–user relationship, self-care and the use of antibiotics. Additionally, it is necessary to train healthcare providers on sharing power, promoting horizontal communication through active listening and building relationships with service users [7577].

Our findings reveal that the most important instruction for antibiotic use includes how to take the drugs and the need to finish them all. But users are not always told the reason why they have to finish the drugs, which is particularly relevant if they feel cured after a day or two. This lack of complete information and communication discourages compliance and is a primary reason for lack of adherence. The contradiction between misconception and antibiotic instruction, while giving instructions for antibiotic use, operates through the prevailing misconceptions of the community members. This interaction can result in stopping or continuing antibiotic use due to misconception about antibiotics and the fear of side effects, which in turn reflects treatment compliance.

This study found that participants universally received instructions for antibiotic use from formal dispensers, whereas those who got their supply from unlicensed sellers did not receive instructions. The main information from the formal sector included how to take the drugs and the need to finish the complete dose, regardless of how well they felt. Notably, users are not always told the reason why they have to finish the drugs, which is particularly relevant if they feel cured after a day or two. Such lack of information discourages compliance and is a primary reason for lack of adherence.

Moreover, it seems that some community members may not fully embrace these explicit guidelines on antibiotic usage due to concerns about potential side effects. This fear of side effects can lead individuals to prematurely discontinue or modify their antibiotic treatment, even if it contradicts the recommended instructions. A previous study found that misunderstanding of the consequences of unnecessary antibiotic use brought about non-adherence [78]. Nevertheless, concerns about side effects are legitimate and healthcare personnel should listen and respond with empathy and professionalism. This empathetic communication is crucial [79].

In addition to misconceptions, fear also leads individuals to prematurely stop or modify antibiotic treatment, despite contradicting the recommended instructions. A study in Saudi Arabia demonstrated that participants would take less of their antibiotics to avoid adverse effects without consulting a healthcare professional [37]. Our findings shed light on the significance of addressing misconceptions and misunderstandings surrounding antibiotic use to improve adherence rates in the community. This highlights the need for comprehensive education and communication efforts to ensure that individuals understand the rationale behind the antibiotic treatment guidelines and feel more confident in adhering to them, especially regarding when and how to take antibiotics. For instance, taking antibiotics as prescribed and knowing when not to use them, particularly with regard to viral infections [80].

Strengths and limitations

The main strength of this study is the integration of dispensers and users. Healthcare providers, suppliers and users of antibiotics provided practical insights on how and why these drugs are controlled and dispensed, how users are instructed and how clients use the drugs.

This study also has several limitations. Because antibiotic dispensing is regulated by a national drug law, our study was not able to obtain empirical information from illegal antibiotic dispensers on selling and dispensing by unqualified persons. This limitation calls for further research that deals with those illegal dispensers; perhaps indigenous field worker sampling (IFWS) is required because it allows local community members who have the advantage of reaching the target sample to be trained as investigators [81]. Additionally, data collection was conducted during 2016 and 2017, and the context may have changed since then.

Conclusions

The evolving practices of antibiotic usage depend on both dispensers and users and their communication. Future interventions should aim to enhance communication between dispensers and users, improve user knowledge and provide clear instructions to facilitate user compliance. Exploring alternative communication channels, such as QR codes, is a viable option. This approach can contribute to reducing one of the major causes of AMR.

Supporting information

S1 File. Research tools.

(PDF)

pone.0298972.s001.pdf (88.1KB, pdf)
S2 File. Healthcare delivery system in Thailand.

(PDF)

pone.0298972.s002.pdf (28.1KB, pdf)

Acknowledgments

The kind cooperation and sharing of information by all the participants made this study possible. We would like to thank all of them. We would also like to thank Jettapon Sangkla, who assisted us with the data collection. Finally, we would like to express our appreciation to Osman Sankoh, Margaret Gyapong, Johannes John-Langba and John Kinsman, who supported the study.

Data Availability

All relevant data are within the article and its Supporting information files. The coding data from the study conducted at the Kanchanaburi Health and Demographic Surveillance System (HDSS) in Thailand is available on Harvard Dataverse (https://doi.org/10.7910/DVN/LMISZU).

Funding Statement

1.The Wellcome Trust, UK 2. The Institute for Population and Social Research, Mahidol University, Thailand.

References

  • 1.World Health Organization. Prioritization of Pathogens to Guide Discovery, Research and Development of New Antibiotics for Drug-Resistant Bacterial Infections, including Tuberculosis. World Health Organization; 2017. [Google Scholar]
  • 2.Tangcharoensathien V, Sommanustweechai A, Chanvatik S, Kosiyaporn H, Tisocki K. Addressing the threat of antibiotic resistance in Thailand: Monitoring population knowledge and awareness. WHO South-East Asia Journal of Public Health. 2018;7(2):73–8. Epub 2018/08/24. doi: 10.4103/2224-3151.239417 . [DOI] [PubMed] [Google Scholar]
  • 3.Thamlikitkul V. STOP antimicrobial resistance: Everybody’s business. Siriraj Medical Journal. 2017;66(6):240–6. [Google Scholar]
  • 4.Sumpradit N, Chongtrakul P, Anuwong K, Pumtong S, Kongsomboon K, Butdeemee P, et al. Antibiotics Smart Use: A workable model for promoting the rational use of medicines in Thailand. Bulletin of the World Health Organization. 2012;90:905–13. doi: 10.2471/BLT.12.105445 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Sumpradit N, Wongkongkathep S, Poonpolsup S, Janejai N, Paveenkittiporn W, Boonyarit P, et al. New chapter in tackling antimicrobial resistance in Thailand. BMJ. 2017;358:j3415. doi: 10.1136/bmj.j2423 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Boonyasiri A, Thamlikitkul V. Effectiveness of multifaceted interventions on rational use of antibiotics for patients with upper respiratory tract infections and acute diarrhea. Journal of the Medical Association of Thailand = Chotmaihet Thangphaet. 2014;97(Suppl 3):S13–19. Epub 2014/04/30. . [PubMed] [Google Scholar]
  • 7.Phueanpinit P, Siriwattanasakul N, Tichakorn P, Klanbut S. Knowledge and perceptions of outpatients regarding upper respiratory tract infections and awareness of an Antibiotics Smart Use campaign in Thailand. Journal of Pharmacy Practice and Research. 2022;52(4):294–302. [Google Scholar]
  • 8.Tangcharoensathien V, Chanvatik S, Kosiyaporn H, Kirivan S, Kaewkhankhaeng W, Thunyahan A, et al. Population knowledge and awareness of antibiotic use and antimicrobial resistance: Results from National Household Survey 2019 and changes from 2017. BMC Public Health. 2021;21(1):2188. doi: 10.1186/s12889-021-12237-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Lopez-Vazquez P, Vazquez-Lago JM, Figueiras A. Misprescription of antibiotics in primary care: A critical systematic review of its determinants. Journal of Evaluation in Clinical Practice. 2012;18(2):473–84. doi: 10.1111/j.1365-2753.2010.01610.x [DOI] [PubMed] [Google Scholar]
  • 10.Goossens H, Ferech M, Vander Stichele R, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: A cross-national database study. Lancet. 2005;365(9459):579–87. doi: 10.1016/S0140-6736(05)17907-0 [DOI] [PubMed] [Google Scholar]
  • 11.Tenover FC. Mechanisms of antimicrobial resistance in bacteria. American Journal of Infection Control. 2006;34(Suppl 5):S3–10. doi: 10.1016/j.ajic.2006.05.219 [DOI] [PubMed] [Google Scholar]
  • 12.Awad AI, Aboud EA. Knowledge, attitude and practice towards antibiotic use among the public in Kuwait. PloS One. 2015;10(2):e0117910. doi: 10.1371/journal.pone.0117910 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Messano GA, Cancrini F, Marsella LT. Antibiotic resistance and defensive medicine, a modern challenge for an old problem: The case of Ureaplasma urealyticum. Igiene e Sanita Pubblica. 2014;70(3):295–304. Epub 2014/09/07. . [PubMed] [Google Scholar]
  • 14.Nicholson A, Tennant I, White L, Thoms-Rodriguez C-A, Cook L, Johnson S, et al. The knowledge, attitudes and practices of doctors regarding antibiotic resistance at a tertiary care institution in the Caribbean. Antimicrobial Resistance & Infection Control. 2018;7(1):23. doi: 10.1186/s13756-018-0315-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Vaz LE, Kleinman KP, Lakoma MD, Dutta-Linn MM, Nahill C, Hellinger J, et al. Prevalence of parental misconceptions about antibiotic use. Pediatrics. 2015:peds. 2015–0883. doi: 10.1542/peds.2015-0883 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Norris P, Chamberlain K, Dew K, Gabe J, Hodgetts D, Madden H. Public beliefs about antibiotics, infection and resistance: A qualitative study. Antibiotics. 2013;2(4):465–76. doi: 10.3390/antibiotics2040465 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Thaler RH, Sunstein CR. Nudge: Improving Decisions about Health, Wealth, and Happiness. Penguin; 2009.
  • 18.The McDonnell Norms Group. Antibiotic overuse: The influence of social norms. Journal of the American College of Surgeons. 2008;207(2):265–75. doi: 10.1016/j.jamcollsurg.2008.02.035 [DOI] [PubMed] [Google Scholar]
  • 19.Touboul-Lundgren P, Jensen S, Drai J, Lindbæk M. Identification of cultural determinants of antibiotic use cited in primary care in Europe: A mixed research synthesis study of integrated design “Culture is all around us”. BMC Public Health. 2015;15(1):908. doi: 10.1186/s12889-015-2254-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Widayati A, Suryawati S, de Crespigny C, Hiller JE. Knowledge and beliefs about antibiotics among people in Yogyakarta City Indonesia: A cross sectional population-based survey. Antimicrobial Resistance and Infection Control. 2012;1(1):38. doi: 10.1186/2047-2994-1-38 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Ratna H. The importance of effective communication in healthcare practice. Harvard Public Health Review. 2019;23:1–6. [Google Scholar]
  • 22.Coxeter P, Del Mar CB, McGregor L, Beller EM, Hoffmann TC. Interventions to facilitate shared decision making to address antibiotic use for acute respiratory infections in primary care. Cochrane Database of Systematic Reviews. 2015;2015(11). doi: 10.1002/14651858.CD010907.pub2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Mathew P, Sivaraman S, Chandy S. Communication strategies for improving public awareness on appropriate antibiotic use: Bridging a vital gap for action on antibiotic resistance. Journal of Family Medicine and Primary Care. 2019;8(6):1867–71. Epub 2019/07/25. doi: 10.4103/jfmpc.jfmpc_263_19 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Sun G, Manzanares K, Foley KA, Zhou Y, MacGeorge EL. Antibiotic stewardship with upper respiratory tract infection patients at student health centers: Providers’ communication experiences and strategies. American Journal of Infection Control. 2023;51(2):154–8. doi: 10.1016/j.ajic.2022.05.013 [DOI] [PubMed] [Google Scholar]
  • 25.Bell BG, Schellevis F, Stobberingh E, Goossens H, Pringle M. A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infectious Diseases. 2014;14:13. Epub 2014/01/11. doi: 10.1186/1471-2334-14-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Bianco A, Licata F, Trovato A, Napolitano F, Pavia M. Antibiotic-dispensing practice in community pharmacies: Results of a cross-sectional study in Italy. Antimicrobial Agents and Chemotherapy. 2021;65(6). Epub 2021/03/31. doi: 10.1128/AAC.02729-20 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Frosch DL, May SG, Rendle KA, Tietbohl C, Elwyn G. Authoritarian physicians and patients’ fear of being labeled ‘difficult’among key obstacles to shared decision making. Health Affairs. 2012;31(5):1030–8. doi: 10.1377/hlthaff.2011.0576 [DOI] [PubMed] [Google Scholar]
  • 28.Kumar S, Little P, Britten N. Why do general practitioners prescribe antibiotics for sore throat? Grounded theory interview study. BMJ. 2003;326(7381):138. doi: 10.1136/bmj.326.7381.138 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Lorenzetti RC, Jacques CM, Donovan C, Cottrell S, Buck J. Managing difficult encounters: understanding physician, patient, and situational factors. American Family Physician. 2013;87(6). [PubMed] [Google Scholar]
  • 30.Scholz B, Bocking J, Happell B. Breaking through the glass ceiling: Consumers in mental health organisations’ hierarchies. Issues in Mental Health Nursing. 2017;38(5):374–80. doi: 10.1080/01612840.2017.1280106 [DOI] [PubMed] [Google Scholar]
  • 31.Gunasekera YD, Kinnison T, Kottawatta SA, Silva-Fletcher A, Kalupahana RS. Misconceptions of antibiotics as a potential explanation for their misuse. A Survey of the general public in a rural and urban community in Sri Lanka. Antibiotics (Basel, Switzerland). 2022;11(4). Epub 2022/04/24. doi: 10.3390/antibiotics11040454 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Afari-Asiedu S, Hulscher M, Abdulai MA, Boamah-Kaali E, Asante KP, Wertheim HFL. Every medicine is medicine: Exploring inappropriate antibiotic use at the community level in rural Ghana. BMC Public Health. 2020;20(1):1103. doi: 10.1186/s12889-020-09204-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Alkhuzaei A, Salama R, Eljak IE, Chehab MAH, Selim NAA. The knowledge, practice, and attitude regarding antibiotic use among attendants of primary health care centres: A cross-sectional study in Qatar. International Journal of Community Medicine and Public Health. 2017;4(11):3969. [Google Scholar]
  • 34.Bagshaw SM, Kellner JD. Beliefs and behaviours of parents regarding antibiotic use by children. Canadian Journal of Infectious Diseases = Journal Canadien des Maladies Infectieuses. 2001;12(2):93–7. doi: 10.1155/2001/250697 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Do NT, Vu HT, Nguyen CT, Punpuing S, Khan WA, Gyapong M, et al. Community-based antibiotic access and use in six low-income and middle-income countries: A mixed-method approach. Lancet Global Health. 2021;9(5):e610–19. doi: 10.1016/S2214-109X(21)00024-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Otaigbe II, Elikwu CJ. Drivers of inappropriate antibiotic use in low- and middle-income countries. JAC-Antimicrobial Resistance. 2023;5(3). doi: 10.1093/jacamr/dlad062 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Alhomoud F, Aljamea Z, Basalelah L. “Antibiotics kill things very quickly”: Consumers’ perspectives on non-prescribed antibiotic use in Saudi Arabia. BMC Public Health. 2018;18(1):1177. doi: 10.1186/s12889-018-6088-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Gaygısız Ü, Lajunen T, Gaygısız E. Community use of antibiotics in Turkey: The role of knowledge, beliefs, attitudes, and health anxiety. Antibiotics (Basel, Switzerland). 2021;10(10). Epub 2021/10/24. doi: 10.3390/antibiotics10101171 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.McCormick JB. How should a research ethicist combat false beliefs and therapeutic misconception risk in biomedical research? AMA Journal of Ethics. 2018;20(11):1100–6. doi: 10.1001/amajethics.2018.1100 [DOI] [PubMed] [Google Scholar]
  • 40.Cross ELA, Tolfree R, Kipping R. Systematic review of public-targeted communication interventions to improve antibiotic use. Journal of Antimicrobial Chemotherapy. 2016;72(4):975–87. doi: 10.1093/jac/dkw520 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Arparsrithongsagul S, Kulsomboon V, Zuckerman IH. Multidisciplinary perspective intervention with community involvement to decrease antibiotic sales in village groceries in Thailand. Asia-Pacific Journal of Public Health. 2015;27(2):Np2480–8. Epub 2013/03/29. doi: 10.1177/1010539513479968 . [DOI] [PubMed] [Google Scholar]
  • 42.Charoenboon N, Haenssgen MJ, Warapikuptanun P, Xayavong T, Khine Zaw Y. Translating antimicrobial resistance: A case study of context and consequences of antibiotic-related communication in three northern Thai villages. Palgrave Communications. 2019;5(1):1–24. [Google Scholar]
  • 43.Altiner A, Brockmann S, Sielk M, Wilm S, Wegscheider K, Abholz H-H. Reducing antibiotic prescriptions for acute cough by motivating GPs to change their attitudes to communication and empowering patients: A cluster-randomized intervention study. Journal of Antimicrobial Chemotherapy. 2007;60(3):638–44. doi: 10.1093/jac/dkm254 [DOI] [PubMed] [Google Scholar]
  • 44.Mangione-Smith R, McGlynn EA, Elliott MN, Krogstad P, Brook RH. The relationship between perceived parental expectations and pediatrician antimicrobial prescribing behavior. Pediatrics. 1999;103(4):711–18. doi: 10.1542/peds.103.4.711 [DOI] [PubMed] [Google Scholar]
  • 45.Wertheim HF, Chuc NTK, Punpuing S, Khan WA, Gyapong M, Asante KP, et al. Community-level antibiotic access and use (ABACUS) in low- and middle-income countries: Finding targets for social interventions to improve appropriate antimicrobial use–an observational multi-centre study. Wellcome Open Research. 2017;2. doi: 10.12688/wellcomeopenres.11985.1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Institute for Population and Social Research Mahidol University. Report of Round 5 Census (2004):Kanchanaburi Project Nakhon Pathom. Institute for Population and Social Research, Mahidol University; 2007: 315. [Google Scholar]
  • 47.Kespichayawattana J, Jitapunkul S. Health and health care system for older persons. Ageing International. 2008;33:28–49. [Google Scholar]
  • 48.World Health Organization. The Kingdom of Thailand health system review. Health Systems in Transition. 2015;5(5). [Google Scholar]
  • 49.Sakunphanit T. Universal Health Care Coverage through Pluralistic Approaches: Experience from Thailand. Bangkok: ILO Subregional Office for East Asia; 2006. [Google Scholar]
  • 50.ICT Services and System Development and Division of Epidemiology and Global Health. OpenCode 4.0. Umeå: University of Umeå, Sweden; 2015. [Google Scholar]
  • 51.Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups. International Journal for Quality in Health Care. 2007;19(6):349–57. doi: 10.1093/intqhc/mzm042 [DOI] [PubMed] [Google Scholar]
  • 52.Pansardi P. Power to and power over: Two distinct concepts of power? Journal of Political Power. 2012;5(1):73–89. [Google Scholar]
  • 53.Friedman D, Kanwat C, Headrick M, Patterson N, Neely J, Smith L. Importance of prudent antibiotic use on dairy farms in South Carolina: A pilot project on farmers’ knowledge, attitudes and practices. Zoonoses and Public Health. 2007;54(9/10):366–75. doi: 10.1111/j.1863-2378.2007.01077.x [DOI] [PubMed] [Google Scholar]
  • 54.Dowse R. Pharmacists, are words enough? The case for pictograms as a valuable communication tool. Research in Social and Administrative Pharmacy. 2021;17(8):1518–22. doi: 10.1016/j.sapharm.2020.10.013 [DOI] [PubMed] [Google Scholar]
  • 55.Kintominas A, Berg L, Farbenblum B. Using Technology to Recruit and Employ Migrant Workers Responsibly: Lessons Learned Report. Bangkok: International Organization for Migration; 2021. [Google Scholar]
  • 56.Pharm SKB, Pharm YNB, Pharm SBB, Rattanaumpawan P, Boonyasiri A, Thamlikitkul V. Epidemiology of antibiotic use and antimicrobial resistance in selected communities in Thailand. Journal of the Medical Association of Thailand = Chotmaihet Thangphaet. 2016;99(3):270–5. [PubMed] [Google Scholar]
  • 57.National Statistical Office of Thailand. The Household Survey on the Use of Information and Communication Technology (Annually) [Internet]. National Statistical Office of Thailand; 2023. Accessed 28 December 2023. https://www.nso.go.th/nsoweb/nso/survey_detail/jJ?set_lang=en. [Google Scholar]
  • 58.Ocan M, Obuku EA, Bwanga F, Akena D, Richard S, Ogwal-Okeng J, et al. Household antimicrobial self-medication: A systematic review and meta-analysis of the burden, risk factors and outcomes in developing countries. BMC Public Health. 2015;15:742. Epub 2015/08/02. doi: 10.1186/s12889-015-2109-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Jamhour A, El-Kheir A, Salameh P, Hanna PA, Mansour H. Antibiotic knowledge and self-medication practices in a developing country: A cross-sectional study. American Journal of Infection Control. 2017;45(4):384–8. doi: 10.1016/j.ajic.2016.11.026 [DOI] [PubMed] [Google Scholar]
  • 60.Sommanustweechai A, Chanvatik S, Sermsinsiri V, Sivilaikul S, Patcharanarumol W, Yeung S, et al. Antibiotic distribution channels in Thailand: Results of key-informant interviews, reviews of drug regulations and database searches. Bulletin of the World Health Organization. 2018;96(2):101–9. Epub 2018/01/02. doi: 10.2471/BLT.17.199679 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Holloway KA, Kotwani A, Batmanabane G, Puri M, Tisocki K. Antibiotic use in South East Asia and policies to promote appropriate use: Reports from country situational analyses. BMJ. 2017;358:j2291. doi: 10.1136/bmj.j2291 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Ekström M, Stevanovic M. Conversation analysis and power: Examining the descendants and antecedents of social action. Frontiers in Sociology. 2023;8:1196672. doi: 10.3389/fsoc.2023.1196672 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Tang SY, Browne AJ, Mussell B, Smye VL, Rodney P. ’Underclassism’ and access to healthcare in urban centres. Sociology of Health & Illness. 2015;37(5):698–714. Epub 2015/02/28. doi: 10.1111/1467-9566.12236 . [DOI] [PubMed] [Google Scholar]
  • 64.Scholz B, Bocking J, Platania-Phung C, Banfield M, Happell B. “Not an afterthought”: Power imbalances in systemic partnerships between health service providers and consumers in a hospital setting. Health Policy. 2018;122(8):922–8. doi: 10.1016/j.healthpol.2018.06.007 [DOI] [PubMed] [Google Scholar]
  • 65.Medina-Perucha L, Garcia-Sangenis A, Moragas A, Galvez-Hernandez P, Cots JM, Lanau-Roig A, et al. Autonomy, power dynamics and antibiotic use in primary healthcare: A qualitative study. PloS One. 2020;15(12):e0244432. doi: 10.1371/journal.pone.0244432 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Afari-Asiedu S, Kinsman J, Boamah-Kaali E, Abdulai MA, Gyapong M, Sankoh O, et al. To sell or not to sell: The differences between regulatory and community demands regarding access to antibiotics in rural Ghana. Journal of Pharmaceutical Policy and Practice. 2018;11(1):1–10. doi: 10.1186/s40545-018-0158-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Francis R. Report of the Mid Staffordshire NHS Foundation Trust Public Inquiry: Executive Summary. The Stationery Office; 2013. [Google Scholar]
  • 68.Joseph-Williams N, Edwards A, Elwyn G. Power imbalance prevents shared decision making. BMJ. 2014;348:g3178. doi: 10.1136/bmj.g3178 [DOI] [PubMed] [Google Scholar]
  • 69.World Health Organization. Health Literacy. The Solid Facts [Internet]. World Health Organization; 2013. Accessed 19 June 2019. http://publichealthwell.ie/node/534072. [Google Scholar]
  • 70.Alhomoud F, Aljamea Z, Almahasnah R, Alkhalifah K, Basalelah L, Alhomoud FK. Self-medication and self-prescription with antibiotics in the Middle East–do they really happen? A systematic review of the prevalence, possible reasons, and outcomes. International Journal of Infectious Diseases. 2017;57:3–12. doi: 10.1016/j.ijid.2017.01.014 [DOI] [PubMed] [Google Scholar]
  • 71.Barker AK, Brown K, Ahsan M, Sengupta S, Safdar N. Social determinants of antibiotic misuse: A qualitative study of community members in Haryana, India. BMC Public Health. 2017;17(1):333. doi: 10.1186/s12889-017-4261-4 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Céspedes A, Larson E. Knowledge, attitudes, and practices regarding antibiotic use among Latinos in the United States: Review and recommendations. American Journal of Infection Control. 2006;34(8):495–502. doi: 10.1016/j.ajic.2006.01.005 [DOI] [PubMed] [Google Scholar]
  • 73.Salm F, Ernsting C, Kuhlmey A, Kanzler M, Gastmeier P, Gellert P. Antibiotic use, knowledge and health literacy among the general population in Berlin, Germany and its surrounding rural areas. PloS One. 2018;13(2):e0193336. doi: 10.1371/journal.pone.0193336 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Shehadeh M, Suaifan G, Darwish RM, Wazaify M, Zaru L, Alja’fari S. Knowledge, attitudes and behavior regarding antibiotics use and misuse among adults in the community of Jordan: A pilot study. Saudi Pharmaceutical Journal. 2012;20(2):125–33. doi: 10.1016/j.jsps.2011.11.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Nimmon L, Stenfors-Hayes T. The “Handling” of power in the physician–patient encounter: Perceptions from experienced physicians. BMC Medical Education. 2016;16:1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Barry CA, Bradley CP, Britten N, Stevenson FA, Barber N. Patients’ unvoiced agendas in general practice consultations: Qualitative study. BMJ. 2000;320(7244):1246–50. doi: 10.1136/bmj.320.7244.1246 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Mead N, Bower P. Patient-centredness: A conceptual framework and review of the empirical literature. Social Science & Medicine. 2000;51(7):1087–110. [DOI] [PubMed] [Google Scholar]
  • 78.Pinder R, Sallis A, Berry D, Chadborn T. Behaviour Change and Antibiotic Prescribing in Healthcare Settings: Literature Review and Behavioural Analysis. Public Health England; 2015. [Google Scholar]
  • 79.Moudatsou M, Stavropoulou A, Philalithis A, Koukouli S. The role of empathy in health and social care professionals. Healthcare (Basel, Switzerland). 2020;8(1). Epub 2020/02/06. doi: 10.3390/healthcare8010026 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Llewelyn MJ, Fitzpatrick JM, Darwin E, Gorton C, Paul J, Peto TE, et al. The antibiotic course has had its day. BMJ. 2017;358. doi: 10.1136/bmj.j3418 [DOI] [PubMed] [Google Scholar]
  • 81.Shaghaghi A, Bhopal RS, Sheikh A. Approaches to recruiting ’hard-to-reach’ populations into research: A review of the literature. Health Promotion Perspectives. 2011;1(2):86–94. doi: 10.5681/hpp.2011.009 . [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Anselme Shyaka

26 Nov 2023

PONE-D-23-33609Understanding antibiotic use in the community setting in Thailand: Does communication matter?PLOS ONE

Dear Dr. Sunpuwan,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

 Please review the suggestions and comments from both reviewers and address the identified concerns. 

Please submit your revised manuscript by Jan 10 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Anselme Shyaka, Ph.D

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Note from Emily Chenette, Editor in Chief of PLOS ONE, and Iain Hrynaszkiewicz, Director of Open Research Solutions at PLOS: 

Did you know that depositing data in a repository is associated with up to a 25% citation advantage (https://doi.org/10.1371/journal.pone.0230416)? If you’ve not already done so, consider depositing your raw data in a repository to ensure your work is read, appreciated and cited by the largest possible audience. You’ll also earn an Accessible Data icon on your published paper if you deposit your data in any participating repository (https://plos.org/open-science/open-data/#accessible-data).

3. Please include a complete copy of PLOS’ questionnaire on inclusivity in global research in your revised manuscript. Our policy for research in this area aims to improve transparency in the reporting of research performed outside of researchers’ own country or community. The policy applies to researchers who have travelled to a different country to conduct research, research with Indigenous populations or their lands, and research on cultural artefacts. The questionnaire can also be requested at the journal’s discretion for any other submissions, even if these conditions are not met.  

Please find more information on the policy and a link to download a blank copy of the questionnaire here: https://journals.plos.org/plosone/s/best-practices-in-research-reporting. 

Please upload a completed version of your questionnaire as Supporting Information when you resubmit your manuscript.

4. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. 

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

5. Thank you for stating the following financial disclosure: 

"1. The Wellcome Trust , UK 

 2. The Institute for Population and Social Research, Mahidol University, Thailand"

  

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. 

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

6. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 

7. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

Dear Dr. Malee Sunpuwan,

Thank you for submitting your manuscript for publication by PLOS ONE.

Please find the reviewers’ comments and suggestions for your consideration and appropriate action.

I am looking forward to receiving your revised manuscript.

Sincerely,

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is a well-written article. The background information and methods used are clearly described, and the results are interpreted in a way that echoes previous research on the same subject. It's a call for better communication in the dispensing of antibiotics.

However, I have minor comments:

p.2, line 30: In the ‘Objective’ section, it should be written ‘to gain a better understanding of the communication around the use’, and not ‘understanding of the use’. You are basing your interpretations on interviews so you cannot really assess antibiotic use, which would have required observational studies.

p.2, line 48: the term ‘beliefs’ seems inappropriate throughout the paper. No definition is provided, and one gets the impression that the authors talk about misconceptions rather than beliefs. It also seems a little patronizing to talk only about the community members’ beliefs– as if healthcare professionals didn’t have beliefs.

p.11, line 266: the term ‘beliefs’ is unclear. Do you mean ‘representations’ ? Because these ‘beliefs’ can come from previous personal experiences, can they only be ‘beliefs’? I strongly recommend that the authors question the use of the term ‘belief’ throughout the document.

p.4, line 90: ‘actors’ should be written instead of ‘factors’, as the authors seem to be referring mainly to individuals or groups, and not to organisations or other types of factors.

p.6, line 134: How is this sub-study linked to the overall study? We would need more information about this.

p.6, line 145: Data collection was carried out in 2016 and 2017, i.e. 6-7 years from now. Are there any reasons for the delay in publishing the results? This fact should be considered as a limitation, as the context may have changed somewhat since then. It would be important for the authors to take this into account in their article.

Methods

p.8, line 185: No private clinics were recruited in the 2nd phase. Why was this?

p.9, line 202: Why was random sampling used to recruit community members? Given the small sample size, other strategies such as snowball sampling with clear selection criteria could have been used. What is the reasoning behind this approach?

p.9, line220: FGD, could you explain a little bit more what you mean by ‘recruited through the community network’?

Study procedures

p.10, line 234: Where did the FGD take place?

Data analysis

p.10, line 242: After the recordings were transcribed, were they translated into English for coding, or was the analysis done in Thai?

Theme 3

p.17, line 415-416: To discuss the link between people’s “beliefs” and their practices regarding the use of antibiotics as being solely causal is rather simplistic and reductive. The influence of a person’s beliefs on their practices is not so simple; other factors may come into play. In the sentence line 416-417 “Antibiotic practices are influenced by individuals’ beliefs”, I should mention that these “beliefs” are not the only factors.

When the participants talk about their fear of side effects and interaction with other medications they are taking, we (as researchers or health professionals) need to take this seriously. These are legitimate concerns we need to listen to, and not some ‘beliefs’ we have to get rid of. If we deny people’s concerns and needs, we will continue to reproduce a very authoritarian and biomedical way of thinking about antibiotic use.

p.21, line 500: what do you mean by ‘at the village level’? It doesn’t seem very clear to me.

p.24, line 527: In this sentence, the example does not refer to a ‘belief’ but rather to the fact that users were not given access to the information they needed, which is quite different from what you write. I recommend changing this sentence.

Reviewer #2: Thanks for an interesting and well-written manuscript, very well done!

I would suggest changing the word “authoritative” in the abstract (line 54) as it seems like a rather “top-down” approach to change behaviors in relation to antibiotic use.

Even though you have attached a document (S2 File), explaining the different healthcare service levels (tertiary, secondary and primary), I would suggest that you include a brief description about this (like 1-2 sentences) in the article to improve readability.

It would be helpful if you could provide some additional information in the text about the community; how do people generally live, occupation, class (rich, poor etc.?), general access to services? In relation to your suggestion on line 496 about QR codes, do people in rural areas typically own a smart phone, for example?

You mention “power” several times in the article, but without providing a clear definition or any references to other scholars that engage with concepts of power. As there are numerous definitions of power in the wider social sciences literature, please include a brief definition of power in the article.

I have highlighted a few sentences/words in the paper that I found difficult to follow, where I would suggest some editing for improved readability.

Please add a reference on line 533 as you have previously stated that: “The literature reveals that access to power and resources is negotiated in everyday life”. What specific literature do you refer to here?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Manuscript comments reviewer.pdf

pone.0298972.s003.pdf (1.6MB, pdf)
PLoS One. 2024 Apr 2;19(4):e0298972. doi: 10.1371/journal.pone.0298972.r002

Author response to Decision Letter 0


17 Jan 2024

January 17, 2024

Anselme Shyaka

Academic Editor

PLoS ONE

Dear editor,

We appreciate the opportunity to resubmit our revised manuscript and would like to extend our gratitude to both you and the reviewers for their positive feedback and constructive comments. We have carefully considered and incorporated the suggested corrections and modifications, and we are delighted to resubmit our manuscript for further consideration.

In response to the detailed suggestions provided by you and the reviewers, we have made significant edits aimed at addressing all identified issues and concerns. The point-by-point response to the questions and comments is outlined at the end of this letter to assist in the review of our revisions.

We would like to express our sincere thanks for the invaluable comments and queries that have allowed us to strengthen our manuscript. We have diligently worked to incorporate your feedback, and we hope that these revisions demonstrate our commitment to improving the quality of our submission.

Thank you once again for this opportunity, and we look forward to the possibility of our manuscript being accepted for publication.

Sincerely yours,

Malee Sunpuwan

(Malee Sunpuwan)

Corresponding author

malee.sun@mahidol.ac.th

+662 4410201 ext.604

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

RESPONSE: Thank you for this suggestion. Our manuscript has been prepared in accordance with the provided guidelines.

2. Note from Emily Chenette, Editor in Chief of PLOS ONE, and Iain Hrynaszkiewicz, Director of Open Research Solutions at PLOS:

Did you know that depositing data in a repository is associated with up to a 25% citation advantage (https://doi.org/10.1371/journal.pone.0230416)? If you’ve not already done so, consider depositing your raw data in a repository to ensure your work is read, appreciated and cited by the largest possible audience. You’ll also earn an Accessible Data icon on your published paper if you deposit your data in any participating repository (https://plos.org/open-science/open-data/#accessible-data).

RESPONSE: Thank you for sharing this valuable information! We were not aware of the significant citation advantage associated with depositing data in a repository. We will definitely consider this for our future work to ensure broader visibility and impact. The idea of earning an Accessible Data icon on published papers is intriguing too.

3. Please include a complete copy of PLOS’ questionnaire on inclusivity in global research in your revised manuscript. Our policy for research in this area aims to improve transparency in the reporting of research performed outside of researchers’ own country or community. The policy applies to researchers who have travelled to a different country to conduct research, research with Indigenous populations or their lands, and research on cultural artefacts. The questionnaire can also be requested at the journal’s discretion for any other submissions, even if these conditions are not met.

Please find more information on the policy and a link to download a blank copy of the questionnaire here: https://journals.plos.org/plosone/s/best-practices-in-research-reporting.

Please upload a completed version of your questionnaire as Supporting Information when you resubmit your manuscript.

RESPONSE: Thank you very much for this information. We have completed the questionnaire on inclusivity in global research and attached it as a supporting file.

4. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match.

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

RESPONSE: Thank you for this suggestion. We have provided the grant numbers as follows: 219403/Z/19/Z.

5. Thank you for stating the following financial disclosure:

"1. The Wellcome Trust , UK

2. The Institute for Population and Social Research, Mahidol University, Thailand"

Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf

RESPONSE: Thank you for this suggestion. We have stated that "The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript."

6. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

RESPONSE: Thank you for the suggestion. We have included captions for Supporting Information files at the end of the manuscript and updated in-text citations, as well as references, to match accordingly.

7. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

RESPONSE: Thank you for your suggestion. We have confirmed that none of the papers in our references have been retracted. To verify this information, we utilized the Zotero program, integrated with the Retraction Watch Database. Additionally, we have included some references to support the definition of power and its related studies

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

________________________________________

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: N/A

________________________________________

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

________________________________________

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

________________________________________

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is a well-written article. The background information and methods used are clearly described, and the results are interpreted in a way that echoes previous research on the same subject. It's a call for better communication in the dispensing of antibiotics.

However, I have minor comments:

p.2, line 30: In the ‘Objective’ section, it should be written ‘to gain a better understanding of the communication around the use’, and not ‘understanding of the use’. You are basing your interpretations on interviews so you cannot really assess antibiotic use, which would have required observational studies.

RESPONSE: We appreciate your suggestion, and we agree with it. We have modified the objective to read: 'This study aims to gain a deeper understanding of communication around the use of antibiotics in the community and seeks potential implementation strategies to change dispensers' and users' practices in communication aspects' (see line 29)

p.2, line 48: the term ‘beliefs’ seems inappropriate throughout the paper. No definition is provided, and one gets the impression that the authors talk about misconceptions rather than beliefs. It also seems a little patronizing to talk only about the community members’ beliefs– as if healthcare professionals didn’t have beliefs.

RESPONSE: Thank you for this suggestion; we agree to use 'misconceptions' instead of 'beliefs' throughout the manuscript when appropriate.

p.11, line 266: the term ‘beliefs’ is unclear. Do you mean ‘representations’ ? Because these ‘beliefs’ can come from previous personal experiences, can they only be ‘beliefs’? I strongly recommend that the authors question the use of the term ‘belief’ throughout the document.

RESPONSE:Thank you for this suggestion; we have concurred with it and have opted to use 'misconceptions' instead of 'beliefs

p.4, line 90: ‘actors’ should be written instead of ‘factors’, as the authors seem to be referring mainly to individuals or groups, and not to organisations or other types of factors.

RESPONSE: Thank you for this suggestion; we have agreed and used 'actors' instead of 'factors (see lines 83)

p.6, line 134: How is this sub-study linked to the overall study? We would need more information about this.

RESPONSE: Thank you for this suggestion; we have added more information on how this sub-study is connected to the overall study. "and consumption, as well as the underlying factors, in six countries across Africa and Asia. Additionally, the project aims to systematically investigate understandings of antibiotic use, along with related health-seeking behaviors and the broader contextual factors influencing these behaviors. As this sub-study is conducted in Thailand, an upper-middle-income country in Asia, it contributes to a better understanding of antibiotic usage". (see lines 138-140).

p.6, line 145: Data collection was carried out in 2016 and 2017, i.e. 6-7 years from now. Are there any reasons for the delay in publishing the results? This fact should be considered as a limitation, as the context may have changed somewhat since then. It would be important for the authors to take this into account in their article.

RESPONSE: Thank you for this suggestion; we have taken it into consideration and included more information on limitations (see lines 636-637). The reason for the delay is that we continued our research on ongoing issues until 2022, and communication challenges persisted during the latest phase of the study (ABACUS II). However, it was not the primary focus then, so we decided to utilize data from ABACUS I.

Methods

p.8, line 185: No private clinics were recruited in the 2nd phase. Why was this?

RESPONSE: Thank you for this comment, we appreciate your comment and have taken it into consideration. We have now included additional information explaining the reasons for not recruiting private clinics in the second phase. Specifically, the explanation states, 'However, since the second phase involved following up on the issues identified in the first phase with the same drug suppliers, the two private clinics declined to participate in this phase (see lines 189-191)

p.9, line 202: Why was random sampling used to recruit community members? Given the small sample size, other strategies such as snowball sampling with clear selection criteria could have been used. What is the reasoning behind this approach?

RESPONSE: Thank you for this question. Since this is the sub-study and one of its objective is to compare across sites in six LMICs we have added the information to make it clear “The selection of community members was made randomly from the HDSS database, which aimed to use standardized methods for studying antibiotic use in six LMICs. This reflected the full geographical range of the site” (see line 207-210).

p.9, line220: FGD, could you explain a little bit more what you mean by ‘recruited through the community network’?

RESPONSE: Thank you; we have added more information to clarify 'recruited through the community network’ by including the following: 'Participants were recruited through the community network, which involved collaboration between the research team and community members in the study areas.” (see lines 226-228).

Study procedures

p.10, line 234: Where did the FGD take place?

RESPONSE: Thank you for this question; we added information on places of conducting IDIs and FGDs 'IDIs were conducted at participants’ houses, clinics, and workplaces, while FGDs were conducted at community canters such as community halls, meeting rooms, pavilions, and temples located in the study areas” (see lines 241-243).

Data analysis

p.10, line 242: After the recordings were transcribed, were they translated into English for coding, or was the analysis done in Thai?

RESPONSE: Thank you for this question. The audio transcription was done in Thai to facilitate data analysis, and the analysis itself was also carried out in Thai (see lines 251-252).

Theme 3

p.17, line 415-416: To discuss the link between people’s “beliefs” and their practices regarding the use of antibiotics as being solely causal is rather simplistic and reductive. The influence of a person’s beliefs on their practices is not so simple; other factors may come into play. In the sentence line 416-417 “Antibiotic practices are influenced by individuals’ beliefs”, I should mention that these “beliefs” are not the only factors.

RESPONSE: Thank you for this point. We agreed that it is not only one factor but also other factors, and we have changed it to. “Although antibiotic practices are influenced by several factors, individuals' misconceptions are one of such factor that affects whether they choose to follow the provided instructions or not.” (see lines 434-437)

When the participants talk about their fear of side effects and interaction with other medications they are taking, we (as researchers or health professionals) need to take this seriously. These are legitimate concerns we need to listen to, and not some ‘beliefs’ we have to get rid of. If we deny people’s concerns and needs, we will continue to reproduce a very authoritarian and biomedical way of thinking about antibiotic use.

RESPONSE: Thank you for this concern. We have considered this suggestion and added more information in the discussion section: 'Nevertheless, concerns about side effects are legitimate, and healthcare personnel should listen and respond with empathy and professionalism. This empathetic communication is crucial (see lines 614-616)

p.21, line 500: what do you mean by ‘at the village level’? It doesn’t seem very clear to me.

RESPONSE: Thank you for raising this question. To provide clarity, we have revised it to say, 'This shows how ingrained this practice is in the community. (see line 460).

p.24, line 527: In this sentence, the example does not refer to a ‘belief’ but rather to the fact that users were not given access to the information they needed, which is quite different from what you write. I recommend changing this sentence.

RESPONSE: Thank you for this suggestion. We have modified the sentence from 'This belief discourages compliance and is a primary reason for the lack of adherence' to 'This lack of complete information and communication discourages compliance and is a primary reason for the lack of adherence' (see line 596-597)

Reviewer #2: Thanks for an interesting and well-written manuscript, very well done!

I would suggest changing the word “authoritative” in the abstract (line 54) as it seems like a rather “top-down” approach to change behaviors in relation to antibiotic use.

RESPONSE: Thank you for this suggestion. We agreed and have replaced the word 'authoritative' with 'trustworthy”. (line 53)

Even though you have attached a document (S2 File), explaining the different healthcare service levels (tertiary, secondary and primary), I would suggest that you include a brief description about this (like 1-2 sentences) in the article to improve readability.

RESPONSE: Thank you; we have included a brief description: 'Thailand's healthcare system comprises three levels—primary (sub-district health-promoting hospitals), secondary (district, provincial, and regional hospitals), and tertiary (university and large private hospitals). Both public and private sectors play vital roles, with public facilities serving about three-fourths of the population. Informal healthcare providers, such as pharmacies and traditional healers, also contribute to the healthcare landscape (more details in S2 File).' (see lines 164-169)"

It would be helpful if you could provide some additional information in the text about the community; how do people generally live, occupation, class (rich, poor etc.?), general access to services? In relation to your suggestion on line 496 about QR codes, do people in rural areas typically own a smart phone, for example?

RESPONSE: Thank you for this suggestion. We have incorporated more information about community characteristics. For instance, "A majority of them, almost two-thirds or 60%, are involved in sales and service, working for wages, and living in non-poor households. All have access to health services under universal healthcare" (see lines 266-268).

Additionally, we have included more statistics about smartphone ownership among migrants and the overall population in Thailand and the study areas (see lines 517-519, 529-531).

You mention “power” several times in the article, but without providing a clear definition or any references to other scholars that engage with concepts of power. As there are numerous definitions of power in the wider social sciences literature, please include a brief definition of power in the article.

RESPONSE: Thank you; we have defined it. In our study, power is described as the ability to influence actions, encompassing both 'power over' and 'power to.' 'Power over' denotes control over decision-making, resources, ideas, and meanings, while 'power to' relates to an individual's ability to take action” (see lines 276-279). Additionally, we have added more information related to the definition of power and related literature in the discussion part (see lines 553-571)."

I have highlighted a few sentences/words in the paper that I found difficult to follow, where I would suggest some editing for improved readability.

RESPONSE: Thank you for the suggestion. We have sent the manuscript to a professional editing and proofreading service. Please find attached the certificate of editing and proofreading.

Please add a reference on line 533 as you have previously stated that: “The literature reveals that access to power and resources is negotiated in everyday life”. What specific literature do you refer to here?

RESPONSE: Thank you for your careful review. We have cited the following reference:

Ekström M, Stevanovic M. Conversation analysis and power: examining the descendants and antecedents of social action. Frontiers in Sociology. 2023;8:1196672.

________________________________________

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

________________________________________

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

________________________________________

In compliance with data protection regulations, you may request that we remove your personal registration details at any time. (Remove my information/details). Please contact the publication office if you have any questions.

Attachment

Submitted filename: Response to Reviewers.docx

pone.0298972.s004.docx (31.2KB, docx)

Decision Letter 1

Anselme Shyaka

2 Feb 2024

Understanding antibiotic use in the community setting in Thailand: Does communication matter?

PONE-D-23-33609R1

Dear Dr. Sunpuwan,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Anselme Shyaka, Ph.D

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: N/A

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

**********

Acceptance letter

Anselme Shyaka

22 Mar 2024

PONE-D-23-33609R1

PLOS ONE

Dear Dr. Sunpuwan,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Anselme Shyaka

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. Research tools.

    (PDF)

    pone.0298972.s001.pdf (88.1KB, pdf)
    S2 File. Healthcare delivery system in Thailand.

    (PDF)

    pone.0298972.s002.pdf (28.1KB, pdf)
    Attachment

    Submitted filename: Manuscript comments reviewer.pdf

    pone.0298972.s003.pdf (1.6MB, pdf)
    Attachment

    Submitted filename: Response to Reviewers.docx

    pone.0298972.s004.docx (31.2KB, docx)

    Data Availability Statement

    All relevant data are within the article and its Supporting information files. The coding data from the study conducted at the Kanchanaburi Health and Demographic Surveillance System (HDSS) in Thailand is available on Harvard Dataverse (https://doi.org/10.7910/DVN/LMISZU).


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES